USFDA issues 5 observations to Dr Reddy's plant in Hyderabad

Dr.Reddy's Laboratories was issued a Form 483 which notifies the company's management of objectionable conditions, with 5 observations.

Source: The Economic Times Healthcare and Biotech News - July 11, 2019 Category: Pharmaceuticals Source Type: news